Advancing research on the role of the gut in metabolic disease.

Led by world renowned experts in metabolic disease, the EraseT2D task force shares Fractyl Health’s mission to build evidence, understand, and ultimately eradicate metabolic disease.

The Erase T2D task force builds on over a decade of discovery uncovering the central role of the gut in metabolic disease and its capacity to signal other parts of the body. With so many questions still unanswered – the task force is charged to advance research by consolidating existing scholarship and catalyzing future discoveries.

This Fractyl Health funded initiative is designed to spur the kind of innovative thinking and fundamental breakthroughs that will point the way toward a future without type 2 diabetes.


The Erase Type 2 Diabetes task force is comprised of the following members:

Alan Cherrington, Ph.D

Professor of Molecular Physiology & Biophysics, Professor of Medicine, and Jacquelyn A. Turner and Dr. Dorothy J Turner Chair in Diabetes Research at Vanderbilt University School of Medicine

Harith Rajagopalan, M.D., Ph.D.

Co-founder and CEO of Fractyl Health

Geltrude Mingrone, M.D., Ph.D.

Professor of diabetes and nutrition at King’s College, London; associate professor of internal medicine at Catholic University of Rome

Dave D’Alessio, M.D.

Professor of medicine and chief of division of endocrinology and metabolism at Duke University School of Medicine

Randy Seeley, Ph.D.

Professor of surgery and director of Michigan Nutrition Obesity Research Center at Michigan School of Medicine

Interested in our research?

More Info About Revita

You are now leaving the website

You are leaving Fractyl’s main website to go to Fractyl’s U.K. site.

By selecting Continue you will be directed to Fractyl’s U.K. site. If you would like to remain on Fractyl’s main site, select the Cancel button.